36 一位 56 歲男性發現右側腎細胞癌合併多處肝轉移，經腎臟切除後，下列治療何者最不適當？
(A)使用 Interleukin-2 治療
(B)使用 Sunitinib 治療
(C)使用 Temsirolimus（mTOR inhibitor）治療
(D)使用放射治療

答案：登入後查看
統計： A(5), B(4), C(2), D(12), E(0) #1060671

詳解 (共 1 筆)

#4041122

Interleukin 2 — Immunotherapy with high-dose bolus IL-2 can activate an immune response against RCC that results in tumor regression in a minority of patients. Although treatment is associated with severe toxicity, responses often persist for many years, even in the absence of additional therapy, and the majority of complete responders remain free of relapse long term.

0
0